Neogenomics Inc (NASDAQ:NEO)

4.61
Delayed Data
As of Apr 27
 -0.14 / -2.95%
Today’s Change
2.98
Today|||52-Week Range
6.10
+10.55%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Neogenomics Inc have a median target of 7.00, with a high estimate of 8.00 and a low estimate of 7.00. The median estimate represents a +51.84% increase from the last price of 4.61.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Neogenomics Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$23.2M
Reporting Date
Apr 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -175.00%
 
 
 
 
 
 
Growthannually -100.00%
 
 
 
 
 
 

Sales

Growthquarterly -7.16%
 
 
 
 
 
 
Growthannually 19.31%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account